Re:Medical-evidence giant Cochrane battles funding cuts and ...
by Fomite on Monday September 04, 2023 @07:38PM
(#37386238)
"incentive compatible" is doing a lot of heavy lifting in that sentence.
Meta-analysis and systematic reviews were done before Cochrane, and will be done after it. And most pharma companies are banking on RCT results - Cochrane can't do systematic reviews before there's multiple studies, so it's significantly further downstream than what makes pharma money.
Meta-analysis and systematic reviews were done before Cochrane, and will be done after it. And most pharma companies are banking on RCT results - Cochrane can't do systematic reviews before there's multiple studies, so it's significantly further downstream than what makes pharma money.